United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United States - English - NLM (National Library of Medicine)

felix pharmaceuticals private limited - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Ireland - English - HPRA (Health Products Regulatory Authority)

lavet pharmaceuticals ltd - marbofloxacin - tablets chewable - 5 mg/tablet - marbofloxacin - canine, feline - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - marbofloxacin - tablets - 5 mg/tablet - marbofloxacin - canine, feline - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - marbofloxacin - tablets - 5 mg/tablet - marbofloxacin - canine, feline - antibacterial

United Kingdom - English - VMD (Veterinary Medicines Directorate)

lavet pharmaceuticals ltd - marbofloxacin - chewable tablet - antimicrobial - cats, dogs

United States - English - NLM (National Library of Medicine)

aspen veterinary resources®, ltd - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - delaquintm  chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - marbofloxacin - chewable tablet - 10 mg/tablet - marbofloxacin - cats, dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - marbofloxacin - chewable tablet - 100 mg/tablet - marbofloxacin - dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - marbofloxacin - chewable tablet - 40 mg/tablet - marbofloxacin - dogs - antibacterial